Skip to main content
OpenTrials
Completed

NCT Number: NCT00370955

The Effect of Hydrodynamic Parameters on Corneal Endothelial Cell Loss After Phacoemulsification

The purpose of this study is to compare two surgical techniques (high vacuum and low vacuum) on corneal endothelium after phacoemulsification.

Completed

Looking for future studies?

Notify Me

Key information

Age range

50 year–70 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Alireza Baradaran Raffiee

Tehran, Tehran Province, 16666, Iran

About this study

Patients aged 50 to 70 years old with moderate lens opacities (nuclear sclerosis of 3+) were included. The exclusion criteria were: 1-previous corneal pathology (dystrophic or degenerative such as Fuchs' endothelial dystrophy or advanced trachoma), 2- pseudoexfoliation syndrome (PEX), 3- history of intra ocular surgery, 4- glaucoma or ocular hypertension, 5- eyes with a history of anterior uveitis, 6- diabetes mellitus, 7- anterior chamber depth (ACD) less than 2.5 mm or more than 4 mm, 8- axial length less than 21 mm or more than 25 mm, 9- density of endothelial cells less than 1500 cells per mm2, 10- polymegatism (CV > 0.4), 11- keratometric astigmatism more than 1.5 Diopters (D), 12- history of contact lens usage, 13- Intra-operative complications (posterior capsule rupture with or without vitreous loss), 14- postoperative uveitis, 15- postoperative surgical wound leakage, 16- deep-set eye, and 17- size of dilated pupil less than 6 mm. Nucleus density was evaluated using the LOCS III classification system Patients were divided in 2 groups randomly: Group 1 included those candidates for phacoemulsification using high hydrodynamic parameter: 400 mmHg vacuum and 40 ml/min flow rate (high vacuum technique) whereas group 2 consisted of patients who underwent phacoemulsification using low hydrodynamic parameters: 200 mmHg vacuum and 20 ml/min flow rate (low vacuum technique). All surgeries were performed by one surgeon using stop and chop technique with sovereign (white star technology) (AMO, USA). During sculpting stage, vacuum was 40mmHg and flow rate is 20ml/min, in both groups. Irrigation aspiration of cortical material and viscoelastic were bimanually and semi automatically performed with flow rate of 30ml/min.

Total ultrasound power and total volume of BSS in both groups were measured. Pachymetry, endothelial cell density, polymegathism, before and 1, 6 and 12 weeks after intervention were also evaluated. Statistically analysis of data included univariate (student t-test and x2) and multivariate (regression model) analysis of postoperative results.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

were:

  • Moderate lens opacity (Nuclear sclerosis 3+)
  • Age between 50 to 70 years

The exclusion criteria were:

  • Previous corneal pathology (dystrophic or degenerative such as Fuchs' endothelial dystrophy or advanced trachoma),
  • Pseudoexfoliation syndrome (PEX),
  • History of intra ocular surgery,
  • Glaucoma or ocular hypertension,
  • Eyes with a history of anterior uveitis,
  • Diabetes mellitus,
  • Anterior chamber depth (ACD) less than 2.5 mm or more than 4 mm,
  • Axial length less than 21 mm or more than 25 mm,
  • Density of endothelial cells less than 1500 cells per mm2,
  • Polymegatism (CV > 0.4),
  • Keratometric astigmatism more than 1.5 Diopters (D),
  • History of contact lens usage,
  • Intra-operative complications (posterior capsule rupture with or without vitreous loss),
  • Postoperative uveitis,
  • Postoperative surgical wound leakage,
  • Deep-set eye, and 17- size of dilated pupil less than 6 mm.

Treatment and study plan

phacoemulsification using either high vacuum or low vacuum techniques

Procedure

All surgeries were performed using Sovereign phacoemulsification system (AMO) using Whitestar technology.

Other names: stop and chop technique

Primary outcomes

  1. Total ultrasound energy dissipated to the eye, total infused fluid, Endothelial cell loss

    Time frame: All patients were examined on postoperative day 1 and weeks 1, 6 and 12.

Sponsors and collaborators

Lead sponsor

Shahid Beheshti University of Medical Sciences

Other

Registry information

Important dates

Study start
2007
Primary completion
2007
Study completion
2007
First posted
Sep 1, 2006
Registry last updated
Dec 25, 2009

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.